December 26, 2014 10:28 PM ET

Capital Markets

Company Overview of Venrock

Company Overview

Venrock is a venture capital and private equity firm specializing in seed, early stage, late-stage, mezzanine, growth capital, and first round investments. The firm may also consider second round investments. It primarily invests in information technology, healthcare, media, and energy and nanotechnology, agtech, biofuels, specialty pharmaceuticals, animal health, biotechnology, drug discovery and development, life sciences, material sciences, digital media and mobile, Internet, Ad Tech, Generics, consumer and consumer health, consumer technology and electronics, enablers, healthcare information technology and services, diagnostics, medical devices, cloud-centric technologies, crowd, fintech...

530 Fifth Avenue

22nd Floor

New York, NY 10036

United States

Founded in 1969

Phone:

212-444-4100

Fax:

212-444-4101

Key Executives for Venrock

Partner and General Partner
Age: 47
Partner Emeritus
Age: 57
Partner and General Partner
Age: 47
Partner
Age: 73
Compensation as of Fiscal Year 2014.

Venrock Key Developments

Venrock Presents at Boston Biotech NY/NJ CEO Conference, Nov-12-2014 through Nov-13-2014

Venrock Presents at Boston Biotech NY/NJ CEO Conference, Nov-12-2014 through Nov-13-2014. Venue: Apella, 450 East 29th Street, New York, New York, United States. Presentation Date & Speakers: Nov-12-2014, Camille D. Samuels, Partner. Nov-13-2014, Camille D. Samuels, Partner.

Venrock Announces Executive Appointments

Venrock announced that Camille Samuels and Doug Dooley have joined the investment team, both in the Palo Alto office. As a Partner, Samuels brings over a decade of venture investing experience to Venrock and will continue her efforts in biotech and consumer health, while expanding her focus to later stage healthcare companies. Formerly an entrepreneur, Dooley will focus on infrastructure technologies and cloud-centric software. Previously, Samuels was a Managing Director at Versant Ventures where she invested in Achaogen (AKAO), Kythera (KYTH), and Novacardia (acquired by Merck), among others. Prior to Versant, she was responsible for business development at Tularik Inc. (acquired by Amgen) and also spent time at Genzyme, Millennium Predictive Medicine and LEK Consulting. Dooley builds on a two-decade career at infrastructure technology companies ranging from large corporations like Cisco and Intel to security and virtualization startups like Neoteris, NetScreen, and RingCube.

Lithium Technologies Reportedly To Acquire Klout

Lithium Technologies, Inc. is seeking to acquire Klout, Inc. from group of investors including Kleiner Perkins Caufield & Byers, Greycroft Partners LLC, Institutional Venture Partners and Venrock, source close to the negotiations said. While the papers have been signed, the deal has yet to close, according to a source close to the negotiations. The majority of the deal is in stock, the source told CNNMoney. Also according to Redem report Lithium Technologies is in the final stages of acquiring the startup for $100 million for a mix of cash and stock. Both Klout and Lithium declined requests for comment on the report.

Similar Private Companies By Industry

Company Name Region
Premier Business Group, LTD. United States
Semaphore Capital Advisors, LLC United States
American Southwest Financial Corp. United States
ProFinance Associates, Inc. United States
Upstream Investment Partners, LLC United States

Recent Private Companies Transactions

Type
Date
Target
Private Placement
December 17, 2014
Phononic Devices, Inc.
Merger/Acquisition
December 2, 2014
Ariosa Diagnostics, Inc.
Private Placement
November 24, 2014
Ascendis Pharma A/S
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Venrock, please visit www.venrock.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.